Live feed08:30:03·188dINSIDERFilingvia QuantisnowChief Scientific Officer Flanagan W. Michael was granted 27,500 shares and covered exercise/tax liability with 13,695 shares, increasing direct ownership by 17% to 94,000 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RNA· Atrium Therapeutics Inc.Health CareOriginal source
